Altitude Sickness

13 registered clinical trials studyying Altitude Sickness.

Status	Trial	Sponsor	Phase
Completed	Hypoxia Adaptation Promotes Cerebral Functional Connectivity With Neuromuscular Efficiency Decrement NCT07018817	Peking Union Medical College	—
Completed	The Effects of Artificial Air Negative Ions on High-Altitude Acclimatization, Serum HIF1, and PWC170 Index NCT07056751	The First Hospital of Putian City, Putian, Fujian	N/A
Unknown	Acetazolamide to Prevent Impending Altitude-illness in Patients With COPD NCT04913389	University of Zurich	Phase 3
Unknown	Effect of Acetazolamide on Right Heart Function at Rest in Lowlanders With COPD Traveling to High Altitude NCT04915365	University of Zurich	Phase 3
Completed	HIGH Altitude CArdiovascular REsearch Latin America Population Study NCT04751292	Istituto Auxologico Italiano	—
Completed	The Psychophysiological Effect of Simulated and Terrestrial Altitude NCT04075565	University of Applied Sciences and Arts of Southern Switzerland	N/A
Withdrawn	Inhaled Budesonide for Altitude Illness Prevention NCT02941510	University of Colorado, Denver	Phase 3
Unknown	Controlled Hyperventilation as Prophylaxis for Acute Mountain Sickness NCT02972411	Hospital del Trabajador de Santiago	N/A
Completed	AZ, MZ, and the Pulmonary System Response to Hypoxia NCT02760121	University of British Columbia	Phase 4
Unknown	Cardio-respiratory Responses During Hypoxic Exercise in Individuals Born Prematurely NCT02780908	Jozef Stefan Institute	N/A
Completed	Efficacy Study of Riociguat and Its Effects on Exercise Performance and Pulmonary Artery Pressure at High Alti NCT02024386	Richard Moon	Phase 4
Completed	Monitoring of the Cerebral Tissue Oxygenation and Perfusion in the Adapting Climber During Sleep in High Altit NCT01465971	Goethe University	—
Completed	Prevention of Altitude Illness With Non-steroidal Anti-inflammatory Study (PAINS) NCT01171794	Stanford University	Phase 3